• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白作为脓毒症的一个指标。

C-reactive protein as an indicator of sepsis.

作者信息

Póvoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragão A, Sabino H

机构信息

Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Almada Portugal.

出版信息

Intensive Care Med. 1998 Oct;24(10):1052-6. doi: 10.1007/s001340050715.

DOI:10.1007/s001340050715
PMID:9840239
Abstract

OBJECTIVE

To determine the use of plasma C-reactive protein (CRP) concentrations, body temperature (BT) and white blood cell count (WBC) in the detection of sepsis in critically ill patients.

DESIGN

All patients admitted for more than 24 h in the intensive care unit (ICU) were prospectively included. Patients were followed up to ICU discharge and each patient-day was classified in one of four categories according to the infectious status: 1) Negative, patient-day without systemic inflammatory response syndrome (SIRS); 2) Definite, patient-day with SIRS and a positive culture; 3) SIRS, patient-day with SIRS and negative or no cultures. The last group was subdivided according to the following criteria: a) new, or persistence of, pulmonary infiltrates, b) the presence of pus in a place known to be sterile. Patient-days without these criteria were classified as SIRS with improbable sepsis (Unlikely), and with one criteria or more as SIRS with probable sepsis (Probable).

SETTING

Medical/surgical intensive care unit.

PATIENTS

Twenty-three patients were followed.

MEASUREMENTS AND RESULTS

A total of 306 patient-days were analysed: 20 Negative, 15 Definite, 63 Unlikely and 208 Probable. The median (range) CRP values for Negative, Unlikely, Probable and Definite groups were as follows: 24.5 (7-86), 34 (5-107), 143 (39-544), and 148 (52-320) mg/l. The plasma CRP levels were significantly related to the infectious status (Negative, Unlikely, Probable or Definite) of the patient-day classification (p < 0.05). Concentrations of CRP in the Negative and Unlikely groups were significantly lower than in the Probable and Definite ones (p < 0.05). A plasma CRP of 50 mg/l or more was highly suggestive of sepsis (sensitivity 98.5%, specificity 75%).

CONCLUSIONS

Daily measurement of CRP is useful in the detection of sepsis and it is more sensitive than the currently used markers, such as BT and WBC.

摘要

目的

确定血浆C反应蛋白(CRP)浓度、体温(BT)和白细胞计数(WBC)在危重症患者脓毒症检测中的应用。

设计

前瞻性纳入所有在重症监护病房(ICU)住院超过24小时的患者。对患者进行随访直至其从ICU出院,根据感染状态将每个患者日分为四类之一:1)阴性,无全身炎症反应综合征(SIRS)的患者日;2)确诊,有SIRS且培养结果为阳性的患者日;3)SIRS,有SIRS且培养结果为阴性或未进行培养的患者日。最后一组根据以下标准进一步细分:a)新出现或持续存在肺部浸润,b)在已知无菌部位有脓液。无这些标准的患者日分类为脓毒症可能性不大的SIRS(不太可能),有一项或多项标准的分类为脓毒症可能性较大的SIRS(可能)。

地点

内科/外科重症监护病房。

患者

对23例患者进行了随访。

测量与结果

共分析了306个患者日:20个阴性、15个确诊、63个不太可能和208个可能。阴性、不太可能、可能和确诊组的CRP中位数(范围)如下:24.5(7 - 86)、34(5 - 107)、143(39 - 544)和148(52 - 320)mg/l。血浆CRP水平与患者日分类的感染状态(阴性、不太可能、可能或确诊)显著相关(p < 0.05)。阴性和不太可能组的CRP浓度显著低于可能和确诊组(p < 0.05)。血浆CRP≥50 mg/l高度提示脓毒症(敏感性98.5%,特异性75%)。

结论

每日测量CRP对脓毒症检测有用,且比目前使用的标志物如BT和WBC更敏感。

相似文献

1
C-reactive protein as an indicator of sepsis.C反应蛋白作为脓毒症的一个指标。
Intensive Care Med. 1998 Oct;24(10):1052-6. doi: 10.1007/s001340050715.
2
Systemic inflammatory response syndrome in the trauma intensive care unit: who is infected?
J Trauma. 1999 Dec;47(6):1004-8. doi: 10.1097/00005373-199912000-00003.
3
Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis?严重烧伤患者的炎症标志物。脓毒症的最佳指标是什么?
Burns. 2007 Mar;33(2):189-94. doi: 10.1016/j.burns.2006.07.001. Epub 2007 Jan 9.
4
Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.降钙素原和C反应蛋白作为危重症儿童全身炎症反应综合征严重程度的标志物。
Intensive Care Med. 2007 Mar;33(3):477-84. doi: 10.1007/s00134-006-0509-7. Epub 2007 Jan 27.
5
[Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].[降钙素原用于心脏手术后感染性与非感染性全身炎症反应综合征的鉴别诊断]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jul;26(7):478-9.
6
The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation.监测全身炎症患者未成熟中性粒细胞血水平的诊断和预后意义。
Crit Care. 2015 Feb 25;19(1):57. doi: 10.1186/s13054-015-0778-z.
7
Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis.降钙素原、C反应蛋白及血清乳酸脱氢酶在细菌性脓毒症、全身炎症反应综合征及系统性念珠菌病诊断中的应用
Infez Med. 2015 Sep;23(3):230-7.
8
C-Reactive Protein and Hemogram Parameters for the Non-Sepsis Systemic Inflammatory Response Syndrome and Sepsis: What Do They Mean?非脓毒症性全身炎症反应综合征和脓毒症的C反应蛋白及血常规参数:它们意味着什么?
PLoS One. 2016 Feb 10;11(2):e0148699. doi: 10.1371/journal.pone.0148699. eCollection 2016.
9
Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.疑似感染的危重新生儿和儿童体内的脂多糖结合蛋白:与降钙素原、白细胞介素-6和C反应蛋白的比较
Intensive Care Med. 2004 Jul;30(7):1454-60. doi: 10.1007/s00134-004-2307-4. Epub 2004 May 4.
10
Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.炎症标志物对重症监护病房中患有全身炎症反应综合征(SIRS)或脓毒症的患者在任意时间点预测肿瘤坏死因子-α和白细胞介素-6的鉴别能力。
Intensive Care Med. 2000 Mar;26 Suppl 2:S170-4. doi: 10.1007/BF02900732.

引用本文的文献

1
The evolution of analytical techniques for multiplex analysis of protein biomarkers.用于蛋白质生物标志物多重分析的分析技术的演变
Expert Rev Proteomics. 2025 Jul;22(7):255-272. doi: 10.1080/14789450.2025.2529185. Epub 2025 Jul 10.
2
Evaluation of the modified quick sequential organ failure assessment scoring system for triage and prognostic assessment in canine emergency and critically ill patients: a retrospective study.改良快速序贯器官衰竭评估评分系统在犬类急诊和重症患者分诊及预后评估中的应用:一项回顾性研究
BMC Vet Res. 2025 Apr 12;21(1):261. doi: 10.1186/s12917-025-04689-w.
3
C-reactive protein to platelet ratio as an early biomarker in differentiating neonatal late-onset sepsis in neonates with pneumonia.
C反应蛋白与血小板比值作为鉴别新生儿肺炎合并新生儿晚发性败血症的早期生物标志物
Sci Rep. 2025 Mar 28;15(1):10760. doi: 10.1038/s41598-025-94845-x.
4
Association of Daily Body Temperature, White Blood Cell Count, and C-reactive Protein With Mortality and Persistent Bacteremia in Patients With Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial.菌血症患者的每日体温、白细胞计数及C反应蛋白与死亡率和持续性菌血症的关联:CAMERA2随机临床试验的事后分析
Open Forum Infect Dis. 2025 Jan 30;12(2):ofaf063. doi: 10.1093/ofid/ofaf063. eCollection 2025 Feb.
5
Combined detection of monocyte distribution width and procalcitonin for diagnosing and prognosing neonatal sepsis.联合检测单核细胞分布宽度和降钙素原用于诊断和预测新生儿败血症。
BMC Infect Dis. 2025 Jan 14;25(1):64. doi: 10.1186/s12879-025-10472-x.
6
Role of the Lymphocyte Count-to-C-Reactive Protein Ratio in the Risk Stratification for High EASE Scores After Living Donor Liver Transplantation: A Retrospective Observational Cohort Study.淋巴细胞计数与C反应蛋白比值在活体肝移植后高EASE评分风险分层中的作用:一项回顾性观察队列研究
J Clin Med. 2024 Dec 2;13(23):7344. doi: 10.3390/jcm13237344.
7
Longitudinal evaluation of manufacturer-specific differences for high-sensitive CRP EQA results.高敏C反应蛋白室间质量评价结果中各厂家特定差异的纵向评估。
Front Mol Biosci. 2024 Aug 8;11:1401405. doi: 10.3389/fmolb.2024.1401405. eCollection 2024.
8
Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis.作为脓毒症生物标志物的五聚体蛋白-3(PTX-3)的研究进展
Front Med (Lausanne). 2024 Jul 3;11:1398024. doi: 10.3389/fmed.2024.1398024. eCollection 2024.
9
Sex differences in clinical presentation and mortality in emergency department patients with sepsis.脓毒症急诊患者的临床表现和死亡率的性别差异。
Ann Med. 2023;55(2):2244873. doi: 10.1080/07853890.2023.2244873.
10
Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis.淋巴细胞与 C 反应蛋白比值作为疑似新生儿败血症的早期败血症生物标志物。
Mediators Inflamm. 2023 May 8;2023:9077787. doi: 10.1155/2023/9077787. eCollection 2023.